“…African American/Black and Hispanic adults are more likely to develop Alzheimer’s disease (AD) than other racial groups, , which is a result of complex and interconnected factors related to structural and systemic racism, “lived experiences,” social determinants of health, comorbidities, and genetics. − Reducing these disparities partially requires a better understanding of molecular changes in AD. Neuropathological differences in AD hallmarks (amyloid-β (Aβ) plaques and tau tangles) have not been reported in African American/Black and non-Hispanic White participants. ,− Some studies have observed that African American/Black participants are more likely to present with both AD and other dementia pathologies; ,− however, this may be dependent on the sampling of participants in the study in terms of community dwelling versus research centers. − Moreover, potential molecular differences between African American/Black and non-Hispanic White participants have recently been reported, particularly in cerebrospinal fluid (CSF) levels of tau biomarkers for AD. ,− CSF levels of total tau and tau phosphorylated at position 181 (p-tau 181 ) were lower overall in African American/Black participants than non-Hispanic White participants regardless of cognitive status, ,− and furthermore, smaller changes in tau levels occurred in African American/Black participants with cognitive decline .…”